227 related articles for article (PubMed ID: 28393637)
1. Using gonadotropin-releasing hormone agonist before frozen embryo transfer may improve ongoing pregnancy rates in hyperandrogenic polycystic ovary syndrome women.
Tsai HW; Wang PH; Lin LT; Chen SN; Tsui KH
Gynecol Endocrinol; 2017 Sep; 33(9):686-689. PubMed ID: 28393637
[TBL] [Abstract][Full Text] [Related]
2. Artificial Cycle with or without a Depot Gonadotropin-releasing Hormone Agonist for Frozen-thawed Embryo Transfer: An Assessment of Infertility Type that Is Most Suitable.
Xie D; Chen F; Xie SZ; Chen ZL; Tuo P; Zhou R; Zhang J
Curr Med Sci; 2018 Aug; 38(4):626-631. PubMed ID: 30128871
[TBL] [Abstract][Full Text] [Related]
3. Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection.
Ozmen B; Sükür YE; Seval MM; Ateş C; Atabekoğlu CS; Sönmezer M; Berker B
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():137-40. PubMed ID: 25461367
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of gonadotropin-releasing hormone (GNRH) agonist before frozen embryo transfer in improving pregnancy outcome and decreasing miscarriage rate in hyperandrogenic polycystic ovary syndrome women: a randomized clinical trial.
Aghahoseini M; Alyasin A; Rashidi S; Samaei-Nouroozi A; Saeidi H; Shabani-Nashtaei M
Minerva Ginecol; 2020 Aug; 72(4):212-218. PubMed ID: 32677772
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome and cost-effectiveness comparisons of artificial cycle-prepared frozen embryo transfer with or without GnRH agonist pretreatment for polycystic ovary syndrome: a randomised controlled trial.
Luo L; Chen M; Wen Y; Zhang L; Zhou C; Wang Q
BJOG; 2021 Mar; 128(4):667-674. PubMed ID: 32783367
[TBL] [Abstract][Full Text] [Related]
6. Endometrial preparation for vitrified-warmed embryo transfer with or without GnRH-agonist pre-treatment in patients with polycystic ovary syndrome: a randomized controlled trial.
Salemi S; Yahyaei A; Vesali S; Ghaffari F
Reprod Biomed Online; 2021 Sep; 43(3):446-452. PubMed ID: 34340936
[TBL] [Abstract][Full Text] [Related]
7. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
8. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Bian J; Shao H; Liu H; Li H; Fang L; Xing C; Wang L; Tao M
Reprod Sci; 2015 Jun; 22(6):758-66. PubMed ID: 25536958
[TBL] [Abstract][Full Text] [Related]
10. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study.
Dong M; Sun L; Huang L; Yi Y; Zhang X; Tan Y; Song G; Liu L; Wei F; Liu F
Reprod Biol Endocrinol; 2020 Jul; 18(1):73. PubMed ID: 32669123
[TBL] [Abstract][Full Text] [Related]
12. Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
Xu Z; Meng L; Pan C; Chen X; Huang X; Yang H
Gynecol Endocrinol; 2019 Feb; 35(2):124-127. PubMed ID: 30303700
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with or without GnRH-agonist before frozen-thawed embryo transfer in patients with PCOS: a systematic review and meta-analysis.
Li J; Lin Z; Mo S; Wang S; Li Y; Shi Q
J Ovarian Res; 2024 Jun; 17(1):130. PubMed ID: 38907340
[TBL] [Abstract][Full Text] [Related]
14. Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism.
Yang W; Yang R; Yang S; Li J; Tu B; Gao C; Wang Y
Gynecol Endocrinol; 2018 Aug; 34(8):715-718. PubMed ID: 29376451
[TBL] [Abstract][Full Text] [Related]
15. Effect of artificial cycle with or without GnRH-a pretreatment on pregnancy and neonatal outcomes in women with PCOS after frozen embryo transfer: a propensity score matching study.
Wang Y; Hu WH; Wan Q; Li T; Qian Y; Chen MX; Tang XJ; Feng Q; Meng XQ; Adu-Gyamfi EA; Ding YB; Geng LH; Lv XY; Zhong ZH
Reprod Biol Endocrinol; 2022 Mar; 20(1):56. PubMed ID: 35337348
[TBL] [Abstract][Full Text] [Related]
16. Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure.
Steiner N; Shrem G; Tannus S; Dahan SY; Balayla J; Volodarsky-Perel A; Tan SL; Dahan MH
Fertil Steril; 2019 Jul; 112(1):98-104. PubMed ID: 31133384
[TBL] [Abstract][Full Text] [Related]
17. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with a GnRH agonist and hormone replacement treatment protocol could not improve live birth rate for PCOS women undergoing frozen-thawed embryo transfer cycles.
Liu X; Shi J; Bai H; Wen W
BMC Pregnancy Childbirth; 2021 Dec; 21(1):835. PubMed ID: 34922467
[TBL] [Abstract][Full Text] [Related]
19. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
20. Obstetric and neonatal outcomes after programmed frozen embryo transfer with or without GnRH agonist for polycystic ovary syndrome: secondary analysis results from a randomized controlled trial.
Jie HY; Hu R; Zhang L; Dong K; Wu C; Wang Q; Luo L
AJOG Glob Rep; 2023 May; 3(2):100201. PubMed ID: 37168544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
